BinD19
2017ZDYFY-BinD19
Phase 2 mab active
Quick answer
BinD19 for Relapsed B-cell Acute Lymphoblastic Leukemia is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Relapsed B-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active